D-0378-2025 Class II Ongoing
FDA drug recall D-0378-2025 was initiated by RemedyRepack Inc. on Mar 24, 2025 and is designated Class II. Reason for recall: CGMP Deviations The recall status is ongoing. Affected quantity: 1,858 30-count blister cards.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 30, 2025
- Initiation Date
- Mar 24, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,858 30-count blister cards
Product description
Clindamycin HCl, 300 mg Capsule, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC; 70518-3772-00
Reason for recall
CGMP Deviations
Distribution pattern
PA
Code information
Lot J0826722-121624 Exp. 12/31/2025 Lot J0820365-111324 Exp. 11/30/2025 Lot J0814691-101624 Exp. 10/31/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0378-2025
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026